Evidence map›Paper›PMID 23165704›Full record

ArticleStem cells (Dayton, Ohio)2013

Human pericytes for ischemic heart repair.

Chien-Wen Chen, Masaho Okada, Jonathan D Proto, Xueqin Gao, Naosumi Sekiya, Sarah A Beckman, Mirko Corselli, Mihaela Crisan, Arman Saparov, Kimimasa Tobita and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Stem cells (Dayton, Ohio), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 142 papers.

0numbers the graph read from it
0cells of the map it votes in
142citing papers in PubMed
15.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

142 citing papers in PubMed, 230 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Pericytes in tissue fibrosis.American journal of physiology. Cell physiology · 2025
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Biology and function of pericytes in the vascular microcirculation.Animal models and experimental medicine · 2023
    Review
  18. Article
  19. Review
  20. Exogenous pericyte delivery protects the mouse kidney from chronic ischemic injury.American journal of physiology. Renal physiology · 2022
    Article

82 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 4 countries.

Chien-Wen ChenDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Masaho Okada
Jonathan D Proto
Xueqin Gao
Naosumi Sekiya
Sarah A Beckman
Mirko Corselli
Mihaela Crisan
Arman Saparov
Kimimasa Tobita
Bruno Péault
Johnny Huard
University of Pittsburgh · USOrthopaedic Hospital · USErasmus MC Cancer Institute · NLNazarbayev University · KZ

Funding

VARIABILITY, STABILITY & SMOOTHNESS OF WALKINGP30AG024827 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JENNIFER S BRACH · 2004 to 2026
$28.6M
Muscle regeneration through stem cell transplantationR01AR049684 · NIAMS · CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS · PI HUARD, JOHNNY · 2002 to 2006
$1.4M
Identification of MAPC in the Walls of Human Fat Tissue BloodR21HL083057 · NHLBI · CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS · PI PEAULT, BRUNO M · 2007 to 2008
$406k
American Heart Association-American Stroke Association 11PRE7490001Medical Research Council G1000816NHLBI NIH HHS R21 HL083057NHLBI NIH HHS R21HL083057NIAMS NIH HHS R01 AR049684NIAMS NIH HHS R01AR49684NIA NIH HHS P30 AG024827
6 · The paper itself

Abstract

Human microvascular pericytes (CD146(+)/34(-)/45(-)/56(-)) contain multipotent precursors and repair/regenerate defective tissues, notably skeletal muscle. However, their ability to repair the ischemic heart remains unknown. We investigated the therapeutic potential of human pericytes, purified from skeletal muscle, for treating ischemic heart disease and mediating associated repair mechanisms in mice. Echocardiography revealed that pericyte transplantation attenuated left ventricular dilatation and significantly improved cardiac contractility, superior to CD56+ myogenic progenitor transplantation, in acutely infarcted mouse hearts. Pericyte treatment substantially reduced myocardial fibrosis and significantly diminished infiltration of host inflammatory cells at the infarct site. Hypoxic pericyte-conditioned medium suppressed murine fibroblast proliferation and inhibited macrophage proliferation in vitro. High expression by pericytes of immunoregulatory molecules, including interleukin-6, leukemia inhibitory factor, cyclooxygenase-2, and heme oxygenase-1, was sustained under hypoxia, except for monocyte chemotactic protein-1. Host angiogenesis was significantly increased. Pericytes supported microvascular structures in vivo and formed capillary-like networks with/without endothelial cells in three-dimensional cocultures. Under hypoxia, pericytes dramatically increased expression of vascular endothelial growth factor-A, platelet-derived growth factor-β, transforming growth factor-β1 and corresponding receptors while expression of basic fibroblast growth factor, hepatocyte growth factor, epidermal growth factor, and angiopoietin-1 was repressed. The capacity of pericytes to differentiate into and/or fuse with cardiac cells was revealed by green fluorescence protein labeling, although to a minor extent. In conclusion, intramyocardial transplantation of purified human pericytes promotes functional and structural recovery, attributable to multiple mechanisms involving paracrine effects and cellular interactions.

Indexed as

AnimalsAntigens, CDBiomarkersCell Culture TechniquesChemokine CCL2Cyclooxygenase 2FibrosisGene ExpressionHeme Oxygenase-1HumansInterleukin-6Leukemia Inhibitory FactorMembrane ProteinsMiceMyocardial InfarctionMyocardiumAntigens, CDBiomarkersCcl2 protein, mouseChemokine CCL2Cyclooxygenase 2Heme Oxygenase-1Hmox1 protein, mouseInterleukin-6Leukemia Inhibitory FactorLif protein, mouseMembrane ProteinsProto-Oncogene Proteins c-sisPtgs2 protein, mouseVascular Endothelial Growth Factor Avascular endothelial growth factor A, mouse

Identifiers

PMID23165704
PMCPMC3572307
OpenAlexW1967942542

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.